Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Optimal two-stage designs for clinical trials with binary response.

P F Thall1, R Simon, S S Ellenberg

  • 1Statistics/Computer & Information Systems Department, George Washington University, Washington, D.C. 20052.

Statistics in Medicine
|May 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phase I-II clinical trial design: a state-of-the-art paradigm for dose finding.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Fludarabine with pharmacokinetically guided IV busulfan is superior to fixed-dose delivery in pretransplant conditioning of AML/MDS patients.

Bone marrow transplantation·2016
Same author

PR1 peptide vaccine induces specific immunity with clinical responses in myeloid malignancies.

Leukemia·2016
Same author

Phase I/II trial of lenalidomide and high-dose melphalan with autologous stem cell transplantation for relapsed myeloma.

Leukemia·2015
Same author

A phase II randomized trial of induction chemotherapy versus no induction chemotherapy followed by preoperative chemoradiation in patients with esophageal cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2013
Same author

Theory and procedures for finding a correct kinetic model for the bacteriorhodopsin photocycle.

The journal of physical chemistry. B·2013
Same journal

Latent Class Log-Linear Models for Estimating Diagnostic Test Accuracy Without a Gold Standard: A Simulation Study.

Statistics in medicine·2026
Same journal

Interpretable Bayesian Modeling for Multireader Multicase Studies: Addressing Overdispersion and Limited Sample Size in Diagnostic Enhancement Evaluation.

Statistics in medicine·2026
Same journal

Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance.

Statistics in medicine·2026
Same journal

Novel Distance Regression for Repeated Outcomes With Missing Data: Applications to Longitudinal and Crossover Studies of Microbiome Beta-Diversity.

Statistics in medicine·2026
Same journal

Optimal Weighted Tests for Replication Studies and the 'Two-Trials Rule' With Multiple Hypotheses.

Statistics in medicine·2026
Same journal

Identifiable Copula-Double-Cox Models: A Fully Parametric Framework for Dependent Right-Censored Survival Data.

Statistics in medicine·2026
See all related articles

This study introduces an optimized two-stage clinical trial design for dichotomous outcomes, allowing early acceptance of the null hypothesis. The efficient design minimizes sample size while maintaining statistical error constraints.

Area of Science:

  • Clinical Trials
  • Biostatistics
  • Medical Research Methodology

Background:

  • Traditional clinical trial designs may require large sample sizes.
  • Early stopping rules can improve trial efficiency.
  • Existing two-stage designs offer opportunities for early hypothesis acceptance.

Purpose of the Study:

  • To present a simple, optimized two-stage randomized clinical trial design.
  • To enable early acceptance of the null hypothesis.
  • To minimize average expected sample size under error constraints.

Main Methods:

  • A two-stage randomized clinical trial design was developed.
  • The design is based on the Ellenberg and Eisenberger methodology.
  • Optimization focused on minimizing average sample size while controlling Type 1 and Type 2 errors.

Related Experiment Videos

Main Results:

  • The optimized design allows for early acceptance of the null hypothesis.
  • Maximum sample size is only slightly larger than single-stage trials.
  • 40-45% of the maximum sample is allocated to the first stage.
  • The probability of early acceptance of the null hypothesis exceeds 0.60.

Conclusions:

  • The proposed two-stage design offers an efficient alternative for clinical trials with dichotomous outcomes.
  • It balances sample size reduction with robust error control.
  • This design facilitates earlier trial conclusions when the null hypothesis is likely true.